Chemocentryx reported $11.57M in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 28458M 2671M
AstraZeneca AZN:LN 24601M 6727M
Bayer BAYN:GR € 36664M 1254M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Chemocentryx CCXI:US $ 11.57M 3.3M
GlaxoSmithKline GSK:LN 20442M 2605M
Glaxosmithkline GSK:US $ 20442M 2605M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 26491M 908M
Omeros OMER:US $ 312.58M 426K
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Teva Pharmaceutical TEVA:IT 21.6B 686M
YTE INCY:US $ 31.84M 0.32M